Immune-Related Adverse Events (irAE) in Cancer Immune Checkpoint Inhibitors (ICI) and Survival Outcomes Correlation: To Rechallenge or Not?

por Albandar, Heidar J., Fuqua, Jacob, Albandar, Jasim M., Safi, Salahuddin, Merrill, Samuel A., Ma, Patrick C.
Publicado 2021

Does the Combined Use of Aspirin and Immunotherapy Result in Better Outcomes in Non-Small Cell Lung Cancer Than Immunotherapy Alone?

por Aiad, Mina, Tahir, Ali, Fresco, Kayla, Prenatt, Zarian, Ramos-Feliciano, Karla, Walia, Jasmit, Stoltzfus, Jill, Albandar, Heidar J
Publicado 2022